Radiopharm Theranostics (RADX) Current Assets (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Radiopharm Theranostics (RADX) has disclosed Current Assets for 2 consecutive years, with $39.9 million as the latest value for Q2 2025.

• Quarterly Current Assets rose 74.43% to $39.9 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $39.9 million through Jun 2025, up 74.43% year-over-year, with the annual reading at $39.9 million for FY2025, 74.43% up from the prior year.
• Current Assets for Q2 2025 was $39.9 million at Radiopharm Theranostics, up from $22.8 million in the prior quarter.
• The five-year high for Current Assets was $39.9 million in Q2 2025, with the low at $22.8 million in Q2 2024.

Peer Comparison